P3 Health Partners (PIII) Common Equity (2019 - 2025)

P3 Health Partners (PIII) has reported Common Equity for 7 consecutive years, with -$155.2 million the latest figure, recorded in Q4 2025.

• Common Equity for Q4 2025 came in at -$155.2 million, down 304.38% year-over-year; the trailing twelve-month figure through Dec 2025 was -$155.2 million (down 304.38% YoY), and the FY2025 annual result was -$155.2 million, down 304.38% from the prior year.
• Common Equity was -$155.2 million for Q4 2025 at P3 Health Partners, down from -$18.7 million in the prior quarter.
• Over five years, Common Equity peaked at $263.0 million in Q1 2022 and troughed at -$272.9 million in Q4 2021.
• Average Common Equity over 5 years is $13.2 million, with a median of $53.9 million recorded in 2025.
• Year-over-year, Common Equity jumped 5559.81% in 2024 and plunged 304.38% in 2025.
• Over 5 years, Common Equity stood at -$272.9 million in 2021, then surged by 102.14% to $5.9 million in 2022, then jumped by 2327.91% to $142.1 million in 2023, then plunged by 46.57% to $75.9 million in 2024, then plunged by 304.38% to -$155.2 million in 2025.
• Per Business Quant data, the three most recent Common Equity figures were -$155.2 million in Q4 2025, -$18.7 million in Q3 2025, and $44.5 million in Q2 2025.